RDGTHealthcare · Pharmaceutical RetailersTicker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 21 of 100 as at 19 Sept 2026 — in the weakest quartile.
Consensus tells you what everyone already believes. The model scores China Jo-Jo Drugstores, Inc. /Old/ on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (100): Smaller than most of the companies we track.
Value (1): The shares cost a lot relative to the profits and assets behind them.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on RDGT, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. RDGT appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 21 Sept 2026, China Jo-Jo Drugstores, Inc. /Old/ returned −99.6% against +17.8% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 76% of US stocks
Cheaper than 99% of US stocks
Cheaper than 92% of US stocks
Cheaper than 39% of US stocks
Higher than 71% of US stocks
Higher than 56% of US stocks
Higher than 17% of US stocks
Higher than 29% of US stocks
Higher than 29% of US stocks
Higher than 40% of US stocks
Higher than 38% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
China Jo-Jo Drugstores, Inc. /Old/ has a market value of $818K and an enterprise value of −$14.6M.
Trailing P/E: −0.1×.
China Jo-Jo Drugstores, Inc. /Old/ employs 64 people.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
| Company | Market cap | TKN rank |
|---|---|---|
| RDGTChina Jo-Jo Drugstores, Inc. /Old/ | $818,004.00 | 21 |
| SCNXScienture Holdings, Inc. | $12.7M | 8 |
| JAGXJaguar Health, Inc.* | $933,700.00 | 57 |
| FEEDENvue Medical, Inc.* | $951,400.00 | — |
| PFSAProfusa, Inc.* | $1.2M | 12 |
| SNYRSynergy CHC Corp.* | $1.3M | — |
| HELPCybin, Inc.* | $1.4M | 45 |
* Nearest Healthcare names by size — few pharmaceutical retailers companies of this scale trade in the US universe.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own China Jo-Jo Drugstores, Inc. /Old/ — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Ridgetech, Inc. (Nasdaq: RDGT) reported its financial results for the fiscal year ended March 31, 2026. The company completed its strategic transition to a wholesale-focused business model.
Why it matters — This is the first look at Ridgetech's financial performance after completing its strategic shift to a wholesale-only model, giving shareholders a baseline for evaluating the new business direction.
Ridgetech Inc. announced that its wholly owned subsidiary, Zhejiang Jiuxin Medicine Co., Ltd., has been elected as a vice-president unit of the Hangzhou Qiantang District Biomedical and Cosmetic High-Quality Development Association, which is set to be officially inaugurated on July 28, 2026.
Why it matters — The vice-president role signals Ridgetech's growing influence and recognition within the regional biomedical industry, which could strengthen its wholesale pharmaceutical distribution business.
As at 19 Sept 2026, China Jo-Jo Drugstores, Inc. /Old/ ranks 21 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (100 of 100).
No analyst covering China Jo-Jo Drugstores, Inc. /Old/ publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for RDGT are extrapolating price history, which says nothing about the business.
China Jo-Jo Drugstores, Inc. /Old/ returned -99.6% over the 12 months to 21 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.
Ridgetech Inc. is a healthcare distribution company that operates in China, focusing on the retailing and wholesale supply of pharmaceutical and other health-related products.
The most recent item we track (PRNewsWire, 31 July 2026): "Ridgetech, Inc. Reports Fiscal Year 2026 Financial Results". Ridgetech, Inc. (Nasdaq: RDGT) reported its financial results for the fiscal year ended March 31, 2026. The company completed its strategic transition to a wholesale-focused business model.
Ridgetech Inc. is a healthcare distribution company that operates in China, focusing on the retailing and wholesale supply of pharmaceutical and other health-related products. Its business includes offline wholesale channels and online distribution platforms that serve pharmacies, hospitals, drug vendors, and retail customers. Ridgetech Inc. offers a broad product mix that includes prescription and over-the-counter medicines, nutritional supplements, traditional Chinese medicine, medical devices, personal and family care items, health food, cosmetics, and daily necessities. The company also operates retail drugstores and online pharmacy services, giving it coverage across both consumer-facing and business-to-business channels. In addition, Ridgetech Inc. is involved in herb farming for selected products sold to other drug vendors. Headquartered in Hangzhou, China, Ridgetech Inc. plays a role in the country’s healthcare supply chain by connecting manufacturers, distributors, and end users through physical and digital commerce channels.
CEO Mr. Ming Zhao · 64 employees · China · https://www.ridgetch.com
